Real World Evidence Services
Scientific Evidence from Real-World Clinical Practice
We support pharmaceutical and biotechnology companies, institutions and research PHARMA centres in generating Real-World Evidence (RWE) through observational and post-authorisation studies, transforming Real-World Data (RWD) into reliable evidence to inform clinical, regulatory and market access decision-making.
By combining expertise in Clinical Operations, Biostatistics, Data Management and digital technologies, we provide comprehensive support throughout the entire project lifecycle.
Areas of Expertise
- Pragmatic Clinical Trials
- PASS and PAES
- Patient registries
- Epidemiological studiesOutcomes and care pathway analyses
Our Services
Assessment of data sources, eligible patient populations, operational feasibility and regulatory requirements.
Definition of study objectives, endpoints, methodology and bias mitigation strategies to deliver robust, fit-for-purpose RWE studies.
Selection of study cohorts and qualification of clinical sites based on data availability and quality.
Design of data collection workflows, implementation of eCRFs and ePROs, and development of validated, analysis-ready databases.
Assessment of dataset completeness, accuracy, traceability and reliability.
Comprehensive statistical support, from study planning and data analysis through to the interpretation of results and scientific publication.
Development and management of tools for collecting and analysing Patient-Reported Outcomes and other clinical outcomes.
Your Partner for Real-World Evidence
We support clinical research stakeholders in generating robust evidence that meets regulatory requirements and creates value for patients, healthcare systems and sponsors.